Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Cretenet, Gaspard ^a   Clerc, Isabelle ^a   Matias, Maria ^a   Loisel, Severine ^a   Craveiro, Marco ^a   Oburoglu, Leal ^a   Kinet, Sandrina ^a   Mongellaz, Cédric ^a   Dardalhon, Valérie ^a   Taylor, Naomi ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; LYMPHOCYTE ANTIGEN RECEPTOR; SLC2A1 PROTEIN, HUMAN;

AEROBIC METABOLISM; ANAEROBIC GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; GLYCOLYSIS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SECRETION (PROCESS); T LYMPHOCYTE SUBPOPULATION;

AEROBIOSIS; ANAEROBIOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 84963823787     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24129     Document Type: Article

References (46)

1. Michalek R. D., et al. Cutting edge: Distinct glycolytic, and lipid oxidative metabolic programs are essential for effector, and regulatory CD4 + T cell subsets. J Immunol 186, 3299-3303, doi: 10.4049/jimmunol.1003613 (2011
2. Shi L. Z., et al. HIF1{alpha}-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17, and Treg cells. J Exp Med 208, 1367-1376, doi: 10.1084/jem.20110278 (2011
3. Wang R., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882, doi: 10.1016/j.immuni.2011.09.021 (2011
4. Berod L., et al. De novo fatty acid synthesis controls the fate between regulatory T, and T helper 17 cells. Nature medicine 20, 1327-1333, doi: 10.1038/nm.3704 (2014
5. Sinclair L. V., et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 14, 500-508, doi: 10.1038/ni.2556 (2013
6. Nakaya M., et al. Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake, and mTORC1 Kinase Activation. Immunity 40, 692-705, doi: 10.1016/j.immuni.2014.04.007 (2014
7. Macintyre A. N., et al. The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation, and Effector Function. Cell metabolism 20, 61-72, doi: 10.1016/j.cmet.2014.05.004 (2014
8. Klysz D., et al. Glutamine-dependent alpha-ketoglutarate production regulates the balance between T helper 1 cell, and regulatory T cell generation. Science signaling 8, ra97, doi: 10.1126/scisignal.aab2610 (2015
9. Hruz P. W., & Mueckler M. M. Structural analysis of the GLUT1 facilitative glucose transporter (review). Mol Membr Biol 18, 183-193 (2001
10. Rathmell J. C., Elstrom R. L., Cinalli R. M., & Thompson C. B. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity, and lymphoma. Eur J Immunol 33, 2223-2232 (2003
11. Frauwirth K. A., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777 (2002
12. Manel N., et al. The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 101, 1913-1918 (2003
13. Yu Q., Erman B., Bhandoola A., Sharrow S. O., & Singer A. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8(+ ) T cells. J Exp Med 197, 475-487 (2003
14. Barata J. T., et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 200, 659-669 (2004
15. Jacobs S. R., Michalek R. D., & Rathmell J. C. IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immunol 184, 3461-3469, doi: 10.4049/jimmunol.0902593 (2010
16. Wofford J. A., Wieman H. L., Jacobs S. R., Zhao Y., & Rathmell J. C. IL-7 promotes Glut1 trafficking, and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 111, 2101-2111, doi: 10.1182/blood-2007-06-096297 (2008
17. Swainson L., et al. IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood 109, 1034-1042 (2007
18. Chakrabarti R., Jung C. Y., Lee T. P., Liu H., & Mookerjee B. K. Changes in glucose transport, and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 152, 2660-2668 (1994
19. Kinet S., et al. Isolated receptor binding domains of HTLV-1, and HTLV-2 envelopes bind Glut-1 on activated CD4+, and CD8+ T cells. Retrovirology 4, 31 (2007
20. Chang C. H., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239-1251, doi: 10.1016/j. cell.2013.05.016 (2013
21. Sukumar M., et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory, and antitumor function. J Clin Invest 123, 4479-4488, doi: 10.1172/JCI69589 (2013
22. Chang C. H., et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell 162, 1229-1241, doi: 10.1016/j.cell.2015.08.016 (2015
23. Ho P. C., et al. Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell 162, 1217-1228, doi: 10.1016/j. cell.2015.08.012 (2015
24. Cham C. M., Driessens G., O?Keefe J. P., & Gajewski T. F. Glucose deprivation inhibits multiple key gene expression events, and effector functions in CD8+ T cells. Eur J Immunol 38, 2438-2450, doi: 10.1002/eji.200838289 (2008
25. Cham C. M., & Gajewski T. F. Glucose availability regulates IFN-gamma production, and p70S6 kinase activation in CD8+ effector T cells. J Immunol 174, 4670-4677 (2005
26. Blagih J., et al. The energy sensor AMPK regulates T cell metabolic adaptation, and effector responses in vivo. Immunity 42, 41-54, doi: 10.1016/j.immuni.2014.12.030 (2015
27. Yin Y., et al. Normalization of CD4+ T cell metabolism reverses lupus. Science translational medicine 7, 274ra218, doi: 10.1126/scitranslmed.aaa0835 (2015
28. Yin Y., et al. Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus. J Immunol, doi: 10.4049/jimmunol.1501537 (2015
29. Semenza G. L. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2, 336-361, doi: 10.1002/wsbm.69 (2010
30. Ben-Shoshan J., Maysel-Auslender S., Mor A., Keren G., & George J. Hypoxia controls CD4+ CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38, 2412-2418, doi: 10.1002/eji.200838318 (2008
31. Dang E. V., et al. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1. Cell 146, 772-784, doi: 10.1016/j.cell.2011.07.033 (2011
32. Shi L. Z., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17, and Treg cells. J Exp Med 208, 1367-1376, doi: 10.1084/jem.20110278 (2011
33. Clambey E. T., et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance, and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci USA 109, E2784-2793, doi: 10.1073/pnas.1202366109 (2012
34. Finlay D. K., et al. PDK1 regulation of mTOR, and hypoxia-inducible factor 1 integrate metabolism, and migration of CD8+ T cells. J Exp Med 209, 2441-2453, doi: 10.1084/jem.20112607 (2011
35. Loisel-Meyer S., et al. Glut1-mediated glucose transport regulates HIV infection. Proc Natl Acad Sci USA 109, 2549-2554, doi: 10.1073/pnas.1121427109 (2012
36. Murakami T., et al. Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J Biol Chem 267, 9300-9306 (1992
37. Ebert B. L., Firth J. D., & Ratcliffe P. J. Hypoxia, and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 270, 29083-29089 (1995
38. Caldwell C. C., et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development, and effector functions. J Immunol 167, 6140-6149 (2001
39. Westermann J., & Pabst R. Distribution of lymphocyte subsets, and natural killer cells in the human body. Clin Investig 70, 539-544 (1992
40. Sopper S., et al. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers, and T-cell turnover in different organs of rhesus monkeys. Blood 10, 10 (2002
41. Zheng Y., Delgoffe G. M., Meyer C. F., Chan W., & Powell J. D. Anergic T cells are metabolically anergic. J Immunol 183, 6095-6101, doi: 10.4049/jimmunol.0803510 (2009
42. Cao Y., Rathmell J. C., & Macintyre A. N. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability, and resistance to metabolic inhibition in CD8 versus CD4 T cells. PLoS One 9, e104104, doi: 10.1371/journal.pone.0104104 (2014
43. Gerriets V. A., et al. Metabolic programming, and PDHK1 control CD4+ T cell subsets, and inflammation. J Clin Invest 125, 194-207, doi: 10.1172/JCI76012 (2015
44. Macheda M. L., Rogers S., & Best J. D. Molecular, and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202, 654-662 (2005
45. Manel N., et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449-459 (2003
46. Kim F. J., et al. HTLV-1, and -2 envelope SU subdomains, and critical determinants in receptor binding. Retrovirology 1, 41, doi: 10.1186/1742-4690-1-41 (2004